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Abstract: There is a gap in the epidemiological data on obesity and COVID-19 mortality in low
and middle-income countries worst affected by the COVID-19 pandemic, including Peru. In this
ecological study, we explored the association between body mass index (BMI), the prevalence of
overweight and obesity, and the COVID-19 mortality rates in 25 Peruvian regions, adjusted for
confounding factors (mean age in the region, mean income, gender balance and number of Intensive
Care Unit (ICU) beds) using multiple linear regression. We retrieved secondary region-level data
on the BMI average and prevalence rates of overweight and obesity in individuals aged ≥ 15 years
old, from the Peruvian National Demographics and Health Survey (ENDES 2020). COVID-19 death
statistics were obtained from the National System of Deaths (SINADEF) from the Peruvian Ministry
of Health and were accurate as of 3 June 2021. COVID-19 mortality rates (per 100,000 habitants) were
calculated among those aged ≥ 15 years old. During the study period, a total of 190,046 COVID-19
deaths were registered in individuals aged ≥ 15 years in 25 Peruvian regions. There was association
between the BMI (r = 0.74; p = 0.00001) and obesity (r = 0.76; p = 0.00001), and the COVID-19 mortality
rate. Adjusted for confounding factors, only the prevalence rate of obesity was associated with
COVID-19 mortality rate (β = 0.585; p = 0.033). These findings suggest that as obesity prevalence
increases, the COVID-19 mortality rates increase in the Peruvian population ≥ 15 years. These
findings can help to elucidate the high COVID-19 mortality rates in Peru.
Keywords: COVID-19; pandemic; overweight; obesity; Peru
1. Introduction
Overweight and obesity are global public health problems [1]. Their prevalence has
increased rapidly during recent decades [2,3], and studies have shown an association
between obesity and infectious diseases [4]. During the COVID-19 pandemic, studies in
high-income countries have shown that obesity increases the risk for hospitalization and
death among patients with COVID-19 [5,6]. Most studies included patients with COVID-19
symptoms admitted to hospital, where obesity itself and the severity of the disease increase
the risk of death [7,8]. Avoiding this bias, one recent study showed that excess weight
linearly increased the risk of severe COVID-19, leading to admission to hospital and death
(body mass index > 28 kg/m2) [9]. In other observational studies, obesity prevalence was
significantly correlated with both infection and/or COVID-19 mortality [10–13]. Despite
these findings, to date, there is a gap of epidemiological data on obesity and COVID-19
mortality in low- and middle-income countries.
In Latin American, Peru has been one of the worst-affected countries by the COVID-19
pandemic [14,15]. Despite the rapid implementation of control measures, by the end of
June 2021, more than two million cases and over 190,000 deaths were confirmed, with a
case fatality rate of 9.31% [16]. In addition, a study in the first months of the COVID-19
pandemic found a correlation between the prevalence of obesity and COVID-19 mortality,
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although its findings are limited [13]. Despite this, it has not been documented how
COVID-19 mortality rates vary according to body mass index (BMI) and the prevalence
of overweight and obesity. Here, we explored the association between body mass index
(BMI), the prevalence of overweight and obesity, and COVID-19 mortality in 25 Peruvian
regions, adjusted by for possible confounding factors.
2. Materials and Methods
2.1. Study Design and Setting
We performed an ecological study following the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guidelines [17]. For this study,
we retrieved secondary region-level data on the BMI average and prevalence rates of
overweight and obesity in individuals aged ≥ 15 years old from the Peruvian National
Demographics and Health Survey (ENDES 2020) [18]. ENDES 2020 includes a sample of
32,197 men and women aged 15 years or more, from 25 Peruvian regions (Figure 1), from
January to December 2020. COVID-19 deaths were obtained from the National System of
Deaths (SINADEF) from the Peruvian Ministry of Health (MINSA), accurate as of 3 June
2021 [19]. The SINADEF database records all deaths that occur in Peru and generates the
death certificates and statistical reports. Death records with COVID-19 as the underlying
cause of death were included in the study. Data on the mean age in the region, mean
income and gender balance were retrieved obtained from the National Institute of Statistics
and Informatics (INEI). The number of Intensive Care Unit (ICU) beds was obtained of
App. F500.2 from at the Superintendencia Nacional de Salud, Perú (SUSALUD).
Trop. Med. Infect. Dis. 2021, 6, x FOR PEER REVIEW 2 of 7 
 
 
pandemic found a correlation between the prevalence of obesity and COVID-19 mortality, 
although its findings are limited [13]. Despite this, it has not been documented how 
COVID-19 mortality rates vary according to body mass index (BMI) and the prevalence 
of overweight and obesity. Here, we explored the association between body mass index 
(BMI), the prevalence of overweight and obesity, and COVID-19 mortality in 25 Peruvian 
regions, adjusted by for possible confounding factors. 
2. Materials and Methods 
2.1. Study Design and Setting 
We performed an ecological study following the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) reporting guidelines [17]. For this 
study, we retrieve  secondary region-level data on the BMI average a  revalence rates 
of overweight and obes ty i  individuals aged ≥ 15 years old from the P ruvian Nation l 
Demographics and Health Surv  ( ES 2020) [18]. ENDES 2020 includes a sample of 
32,197 men and women aged 15 years or more, from 25 Peruvian regions (Figure 1), from 
January to December 2020. COVID-19 deaths were obtained from the National System of 
Deaths (SINADEF) from the Peruvian Ministry of Health (MINSA), accurate as of 3 June 
2021 [19]. The SINADEF database records all deaths that occur in Peru and generates the 
death certificates and statistical reports. Death records with COVID-19 as the underlying 
cause of death were included in the study. Data on the mean age in the region, mean 
income and gender balance were retrieved obtained from the National Institute of 
Statistics and Informatics (INEI). The number of Intensive Care Unit (ICU) beds was 
obtained of App. F500.2 fro  at the Superintendencia Nacional de Salud, Perú 
(SUSALUD). 
 
Figure 1. Location of Peru within South American. 
  
Figure 1. Location of Peru within South American.
2.2. Statistical Analysis
COVID-19 mortality rates (per 100,000 habitants) among those aged ≥ 15 years old
were calculated by dividing the number of COVID-19 deaths per department by the
estimated population of each department. Population counts for calculating mortality rates
were obtained from the INEI, Peru [20]. Spearman’s test and linear regression models were
used to estimate correlations between the BMI, the prevalence of overweight and obesity,
and COVID-19 mortality rates. Multiple regression analysis was also used for possible
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confounding factors. p-values < 0.05 were considered significant. Confounding factors
included the mean age in the region (years), mean monthly income (PEN), gender balance
and number of ICU beds. Statistical analyses were conducted using StataSE 16.0 Software.
This study was based on public use data that do not include personal information;
therefore, it was exempt from institutional review board approval.
3. Results
During the study period, a total of 190,046 COVID-19 deaths were registered in
individuals aged ≥ 15 years in 25 Peruvian regions. Among the individuals aged ≥ 15 years
old, the highest prevalence rates of overweight and obesity were registered in Tacna,
Moquegua, and Ica regions. The five regions with the highest COVID-19 mortality rates
were Ica (1083.6 per 100,000 habitants), Callao (1071.3 per 100,000 habitants), Lima (979.9
per 100,000 habitants), Moquegua (883.3 per 100,000 habitants), and Lambayeque (811.4
per 100,000 habitants) (Table 1).
Table 1. BMI average, prevalence of overweight and obesity, and COVID-19 mortality rate in ≥15-year-olds in 25 Peruvian






































Amazonas 26.2 36.1 15.8 1135.0 289,802.0 391.6 30.95 1014.0 1.07 19
Ancash 26.9 35.6 21.8 6373.0 876,703.0 726.9 32.36 1230.9 1.01 62
Apurimac 25.8 33.2 14.7 1401.0 300,395.0 466.4 29.99 1123.8 1.05 38
Arequipa 28.0 36.8 28.8 8519.0 1,187,931.0 717.1 32.45 1703.1 0.95 92
Ayacucho 25.9 33.9 15.5 1949.0 464,136.0 419.9 30.04 970.6 1.04 20
Cajamarca 25.9 38.6 13.9 3839.0 1,016,792.0 377.6 30.71 954.4 0.98 61
Callao 28.4 35.3 31.8 9670.0 902,609.0 1071.3 32.36 1579.6 0.94 113
Cusco 26.2 36.6 16.8 4390.0 988,897.0 443.9 30.34 1234.1 1.02 50
Huancavelica 24.9 30.8 9.6 1079.0 236,955.0 455.4 30.28 742.1 1.01 21
Huanuco 26.2 36.9 15.9 2558.0 524,371.0 487.8 30.01 1007.1 1.01 44
Ica 28.4 36.5 33.5 7863.0 725,610.0 1083.6 30.93 1507.5 0.99 84
Junin 26.4 39.3 17.0 6570.0 982,199.0 668.9 31.18 1206.3 0.98 77
La
Libertad 27.9 38.5 27.8 9778.0 1,531,668.0 638.4 31.55 1307.5 0.97 96
Lambayeque 27.5 39.5 25.0 8042.0 991,121.0 811.4 32.24 1203.6 0.93 86
Lima 28.1 37.0 28.9 85,748.0 8,750,417.0 979.9 33.05 1885.9 0.91 845
Loreto 26.4 29.6 22.1 3977.0 680,927.0 584.1 28.50 1231.5 1.08 52
Madre de
Dios 28.5 43.9 32.4 727.0 135,428.0 536.8 27.48 1665.0 1.37 25
Moquegua 28.7 37.7 35.8 1374.0 155,545.0 883.3 32.85 1801.5 1.17 28
Pasco 26.3 37.7 17.2 961.0 195,114.0 492.5 30.12 1172.0 1.07 31
Piura 27.2 34.2 25.0 11,414.0 1,535,433.0 743.4 30.42 1146.0 1.01 109
Puno 26.8 37.9 20.4 3603.0 904,267.0 398.4 29.72 876.1 0.96 42
San
Martin 26.4 36.5 19.9 2833.0 639,533.0 443.0 29.89 1159.2 1.14 49
Tacna 28.7 38.7 34.4 1821.0 303,701.0 599.6 31.91 1392.3 1.04 32
Tumbes 27.8 40.0 27.6 1489.0 191,850.0 776.1 29.91 1264.3 1.20 17
Ucayali 26.9 37.7 22.0 2933.0 416,932.0 703.5 28.00 1174.4 1.13 37
BMI: body mass index (kg/m2). ICU: Intensive Care Unit.
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There was an association between BMI (r = 0.74; p = 0.00001) and obesity (r = 0.76;
p = 0.00001) and the COVID-19 mortality rate (per 100,000 habitants) (Figure 2A–C). Ad-
justed by possible confounding factors (mean age in the region, mean monthly income,
gender balance and number of ICU beds), only the prevalence rate of obesity was associated
with COVID-19 mortality rate (β = 0.585; p = 0.033) (Table 2). The model was statistically
significant (F (5,19) = 8.89, p < 0.0002, Adj. R2 = 0.60).
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Table 2. Multiple regression analysis of prevalence of obesity and COVID-19 mortality adjusted.
Variable Coef. SE Beta t p-Value
BMI and COVID-19 mortality
BMI (kg/m2) 94.49 51.60 0.479 1.83 0.083
Mean age in the region (years) −5.58 32.62 −0.038 −0.17 0.866
Mean monthly income (PEN) 0.262 0.23 0.359 1.10 0.285
Gender balance (men/women) −707.0 482.3 −0.336 −1.47 0.159
No. of ICU beds 0.028 0.251 0.021 0.11 0.911
Obesity and COVID-19
mortality
Prevalence of obesity (%) 16.76 7.28 0.585 2.3 0.033
Mean age in the region (years) −2.52 31.2 −0.017 −0.08 0.937
Mean monthly income (PEN) 0.17 0.23 0.240 0.75 0.464
Gender balance (men/women) −693.81 462.6 −0.330 −1.5 0.15
No. of ICU beds 0.08 0.24 0.068 0.36 0.72
BMI: body mass index (kg/m2). ICU: Intensive Care Unit.
4. Discussion
During the COVID-19 pandemic, older adults and people with co-morbidities, includ-
ing patients with obesity, have experienced the highest risk of COVID-19 death [6–8,21]. A
previous cohort study reported that, compared with patients with a BMI of 18.5–24 kg/m2,
patients with BMI ≥ 40 kg/m2 had a higher risk of COVID-19 death [7]. Recently, another
study reported that the risk of COVID-19 death was more strongly associated with people
with a BMI of more than 28 kg/m2 [9]. Our findings, despite being correlational, support
this observation, because in the Peruvian regions where the BMI was higher (i.e., Tacna,
Moquegua and Ica), we found higher COVID-19 mortality rates. However, adjusted by
possible confounding factors, there was not association between the BMI and COVID-19
mortality rates. To date, there is little evidence on the mechanisms attributable to BMI
effects on COVID-19 mortality. A possible explanation is that excess weight can cause
the metabolic impairment of organ functioning [22]. Other possible explanations for BMI
increasing COVID-19 mortality could be associated with the severity of COVID-19, male
sex, increasing age, and other factors that were not investigated in this study.
In our study, there was correlation between the prevalence of obesity and COVID-
19 mortality, i.e., as the obesity prevalence increased, the COVID-19 mortality rates in-
creased in the population aged ≥ 15 years. These findings are consistent with correlational
studies which found that, as the obesity prevalence increased, the COVID-19 deaths
increased [10–13]. Cohort studies and meta-analyses on the effect of excess weight on
COVID-19 clinical outcomes also reported that obesity was independently associated with
the severity of COVID-19 and the risk of death increased [7,8]. The increase in COVID-19
mortality in patients with obesity could be explained by associations with hypertension, di-
abetes, or respiratory distress syndrome [7,9]; however, to date, the mechanisms explaining
the association between obesity and COVID-19 mortality remain limited. In Peru, obesity
and high COVID-19 mortality also could be explained by other external factors, such as
infrastructure, overload of the health system, medicines, and available intensive care unit
beds [14,15].
As with any observational study, the limitations of our study include its ecological
design, because we used several different information sources (ENDES 2020, SINADEF,
INEI, and SUSALUD); therefore, our findings could have resulted in a possible bias. In our
findings, there could also have been an overestimation due to unmeasured covariates, such
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as the population density, and delayed COVID-19 death registration. On the other hand, the
ecological design (group level variables) made it difficult to determine causality between
the obesity and the COVID-19 mortality, i.e., we cannot make causal inference with the
average characteristics of the group about individual risk. Therefore, our findings should be
interpreted at the population level, not the individual-level. Finally, the ecological design is
not able to account for changes that impact transmission dynamics, such as the appearance
of new variants of concern or the introduction of vaccination. Despite these limitations,
the main strengths of our study were the large number of deaths included (n = 190,046, as
of June 2021) for estimating the COVID-19 mortality and the multiple regression analyses
for possible confounding factors (mean age in the region, mean monthly income, gender
balance and number of ICU beds), compared with a previous study that included a total of
51,789 deaths (as of July 2020) [13].
5. Conclusions
Our findings suggest that, as the obesity prevalence increases, the COVID-19 mortality
rates increase in Peruvian populations aged ≥ 15 years. Interventions for obesity improve
weight loss; however, we cannot assure that these interventions might reduce COVID-19
mortality. In the long term, there is a need to strive towards achieving healthy weights in
the Peruvian population and to decrease the risk of death from other infections in future.
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